LexDanaLexDanabeta
Inventor

Masayasu Kurono

Inventor
Mie, JP

Overview

75→
Patents
1978–1996
Patent span
Human necessities
Primary field (CPC A)

Patents· 75 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides5%
A61LMethods or apparatus for sterilising materials or objects in general2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
A61QSpecific use of cosmetics or similar toiletry preparations1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
5,552,157'Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation'19965,530,138'Compounds and use thereof'19965,474,913'Process for the preparation of motilin-like polypeptide and expression thereof'19955,474,908'Method of enzymatically measuring hydrogen peroxide and reagent therefor'19955,468,728'Use of orally absorbable motilin preparations to enhance motility of digestive tract'19955,459,049'Motilin-like polypeptide and use thereof'19955,447,946'Hydantoin derivatives for treating complications of diabetes'19955,434,082'Early diagnosis of mastitis or garget'19955,434,165'Nootropic agents, compositions of, and method of use thereof'19955,432,261'Motlin-like polypeptide and use thereof'19955,428,015'Vasoactive intestinal polypeptide analogues and use thereof'19955,376,637'Pharmaceutical preparation containing vasoactive intestinal polypeptide or its analogue'19945,364,533'Process for separating serum and plasma'19945,356,880'Glycyrrhetinic acid derivatives'19945,340,806'Composition containing organogermanium compound and immunity adjusting agent comprising the composition'19945,336,688'Composition containing organogermanium compound and immunity adjusting agents comprising the compositions'19945,308,836'Pharmaceutical composition of stabilized [Leu.sup.13 ]-motilin-Hse'19945,290,679'Method of predicting threatened premature delivery in a pregnant woman'19945,279,835'Binder-free orally administrable tablet containing 3-oxygermylpropionic acid'19945,260,056'Composition for enhancing biosynthesis of interferon'19935,260,064'Percutaneous-administration-type pharmaceutical preparation of nitroglycerin'19935,240,700'Pharmaceutical composition comprising a medicament and 3-oxygermylpropionic acid'19935,211,956'Pharmaceutical compositions containing phytic acid or its salts'19935,180,739'Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent type of autoimmune diseases'19935,177,102'Polyisoprene compounds and salts thereof'19935,171,865'Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof'19925,166,388'Stabilized composition of phytic acid'19925,164,391'Hydantoin derivatives for treating complications of diabetes and circulatory diseases'19925,155,125'Method of treating gastrointestinal ulcers with spiro hydantoins'19925,118,503'Composition obtained from rice bran and use thereof'19925,110,945'1-azoniabicyclo[3.3.0]oct-1(5)-ene salt derivatives and process for the preparation of the same'19925,106,735'Cloning of a DNA sequence encoding a Sarcophaga peregrina antibacterial polypeptide precursor'19925,089,265'Stabilized phytic acid compositions'19925,061,691'Enkephalin analogs'19915,059,594'Phytic acid compositions'19915,041,429'Cell activators, circulatory ameliorators and edible compositions'19915,037,981'Intermediates for synthesizing BH.sub.4 and its derivatives'19915,036,080'(D)-6-fluoro-2,3-dihydro-2\',5-dioxo-spiro[4H-1-benzo pyran-4,4\'-imidazolide]-2-carboxamide compounds'19915,017,486'Cloning of DNA encoding antibacterial polypeptide precursor'19915,008,416'Organogermanium compound, process for the preparation of same as well as use thereof'19915,001,240'Process for preparing optically active hydantoins'19914,987,150'Agent for inhibiting binding of 5-dihydro-testosterone with androgen receptor as well as process for obtaining same'19914,985,356'Cloning of DNA encoding human motilin precursor and expression of the precursor'19914,985,574'Hydantoin derivatives for treating complications of diabetes'19914,985,573'Hydantoin derivatives for treating complications of diabetes'19914,985,569'Pyrrolizine derivative and its manufacture'19914,978,758'Hydantoin derivatives for treating complications of diabetes'19904,971,799'Percutaneous-administration-type pharmaceutical preparation of nitroglycerin'19904,970,088'Liquid food for supplying protein'19904,952,568'Remedies and preventives for diabetic diseases'19904,939,126'1-pyrrolidineacetamide derivatives and use thereof'19904,937,342'Intermediates for synthesizing BH.sub.4 and its derivatives'19904,929,438'Preventives and remedies for medicinal and alcoholic poisoning'19904,914,121'3-Phenyl-1-phenylpyrazole-4 acetic acid compounds which are useful in treating immune diseases'19904,906,477'Antineoplastic agent-entrapping liposomes'19904,897,495'Process for the preparation of pyrrolizine derivatives'19904,889,715'Composition containing organogermanium compound and immunity adjusting agent comprising the composition'19894,871,740'Glycyrrhetic acid derivatives and use thereof'19894,870,062'Organo-platinum complex and use thereof as anti-tumor agent'19894,868,189'Uracil derivatives for use as anti-tumor agents having silicon containing side chains'19894,861,792'Hydantoin derivatives for treating complications of diabetes'19894,857,521'Trialkylsilyl pyridinium cephalosporin antibiotics'19894,824,855'1,4-dihydropyridine derivatives'19894,778,797'Organo-silicon compounds, process for the manufacture of same, and anti-tumor agent comprising the compound'19884,740,517'Antidiabetic spiro-3-heteroazolidines'19884,734,411'Pyrrolizidine compounds, salts thereof, process for the preparation of same and pharmaceutical agents comprising same'19884,678,801'Novel 2-oxopyrrolidine compounds, salts thereof process for the preparation thereof as well as pharmaceutical agent comprising the compound'19874,656,303'Novel resolution method of racemic mixture'19874,560,679'Organosilicon compounds and antitumor agents containing the compound as effective component'19854,528,184'Polymer-metal complexes containing quaternary nitrogen atoms used in the treatment of hypercholesteremia'19854,528,143'Process for the preparation of 4-chloro-2-nitrobenzonitrile'19854,275,075'15-cylobutyl-trans-.DELTA..sup.2 -prostaglandin analogues'19814,208,428'Prostaglandin analogues'19804,131,747'Process for preparing .alpha.-substituted phenylalkanecarboxylic acid'19784,124,765'5-Fluorouracil derivatives'1978

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1978–1981Patents assigned to ONO PHARMACEUTICAL CO (4)· patent assignee history
1978–1981Based in Osaka, JP· patent location history
1985–1996Patents assigned to SANWA KAGAKU KENKYUSHO CO (58)· patent assignee history
1985–1991Patents assigned to VITAMIN KENKYUSO KK (3)· patent assignee history
1985–1996Based in Nagoya, JP· patent location history
1987–1996Based in Mie, JP· patent location history
1989–1995Based in Aichi, JP· patent location history
1989Based in Sasao, JP· patent location history
1990–1993Patents assigned to NIPPON OILS & FATS CO LTD (3)· patent assignee history
1990–1991Patents assigned to VITAMIN KENKYUSHO KK (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANWA KAGAKU KENKYUSHO CO581985–1996
ONO PHARMACEUTICAL CO41978–1981
NIPPON OILS & FATS CO LTD31990–1993
VITAMIN KENKYUSHO KK31990–1991
VITAMIN KENKYUSO KK31985–1991
Locations
LocationPatentsSpan
Mie, JP281987–1996
Nagoya, JP261985–1996
Aichi, JP161989–1995
Osaka, JP41978–1981
Sasao, JP11989